L7 | ESP™

BEBPA 2021 EUR Bioassay Conference (Sept. 20-23, 2021)

Welcome to our virtual booth!

who we are

L7 Informatics is a leader in enterprise-scale digital transformation and automation of scientific processes in the life sciences and healthcare. L7’s mission is to revolutionize scientific process and data management to accelerate precision health across life sciences, healthcare, and nutrition value chains. Our end-to-end solutions and services yield efficiencies that enable researchers to make new genomics discoveries, precision therapeutics manufacturers to create higher fidelity therapies, health systems to provide superior diagnostics and standard of care, and precision agriculture to meet tomorrow’s nutrition needs through improvements to crops and livestock.

Our platform, L7|ESP, is a unified and composable platform with a single data fabric that reduces the total cost of operations while enabling digital transformation. This FDA regulatory compliant platform comes with several pre-built best-in-class apps: ELN, LIMS, Sample Management, Inventory, Analysis, EBR (Electronic Batch Record), Dashboards, Data, Intelligence, EM (Environmental Monitoring), Builders, Search, etc. L7|ESP’s REST API library and Python SDK enable flexibility and extensibility to meet customer-specific requirements. We are continuously adding new applications with each release.

Our approach breaks down barriers by providing streamlined processes and better data management across all functionalities. We integrate L7 solutions with external, in-house, and open-source tools to create a seamless workflow. We develop and deliver customized, end-to-end solutions that integrate seamlessly and scale with your entity for future growth by working closely with our customers and partners.

 

 

presenting L7|ESP: precision solutions for science + health

Precision health is bringing biology to the forefront of scientific discovery and human health. Yet, today’s data silos and outdated and disjointed systems delay progress, increase costs, and put patients at risk. Realizing the incredible potential of precision health requires a new, digitally-enabled approach to how science gets done.

 

what makes L7|ESP an ideal operating system for your lab?

L7 is the premier FDA compliant operating platform for science in the precision era. Unlike traditional LIMS, ELNs, and other data management systems built for a single purpose, L7’s integrated software solutions tailor workflows for your specific needs, enabling rapid assessment of lab operations or treatment protocols while automating data analysis, visualization, and reporting.

L7’s solutions and services are built for today’s complex and constantly evolving precision lab and clinical environments. Rather than a one-size-fits all approach, L7 overlays and connects legacy systems and provides access to hundreds of pre-built apps and connectors alongside a continuously growing content library. Limitlessly customizable and composable, L7 even allows users to build their own solutions using our low-code development tool, L7|Master.

executive team

Vasu Rangadass

Vasu Rangadass

President & CEO

Marcia Blackmoore

Marcia Blackmoore

Chief Commercial Officer

management team

Robert Zeigler

Robert Zeigler

Vice President, Product Development

Kara Walker

Kara Walker

Vice President, Finance & HR

James Ryan

James Ryan

Vice President, Research

Jessica Tobey

Jessica Tobey

Vice President, Marketing

Sumit Rao

Sumit Rao

General Manager, India

J.P. Brown

J.P. Brown

Vice President, Customer & Partner Enablement

L7’s clients + partners

we’re hiring

the latest about L7 Informatics

Cell Therapy Cannot Scale Without Digital Continuity Across R&D, CMC,...

Cell therapy programs don't fail because of bad science; they fail because context doesn't travel. This article explores how ontologies,
document
Blog

Modernization was the First Chapter, Digital Differentiation is the Next...

Life sciences organizations have invested heavily in digital transformation, but modernization alone does not create a competitive advantage. Vasu Rangadass,
document
Blog

From AI-Ready to AI-Actionable: Why Life Sciences Need an Execution...

Life sciences organizations have invested in AI-ready data infrastructure. The next step is becoming AI-actionable: enabling AI to participate inside
document
Blog

Building the Digital Backbone for Scalable Cell Therapies: Key Insights...

This panel discussion from Cell and Gene Meeting on the Mesa 2025 brings together leaders from Dana-Farber Cancer Institute, CTMC,
document
Blog